Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-04-01

FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for DICLOFENAC SODIUM AND MISOPROSTOL from Mylan Pharmaceuticals, updating the labeling for this diclofenac/misoprostol …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac sodium and misoprostol (diclofenac sodium and misoprostol)

Snippet

SUPPL AP for DICLOFENAC SODIUM AND MISOPROSTOL (DICLOFENAC SODIUM AND MISOPROSTOL)